Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo

Uveal melanoma is a rare but often lethal malignancy and is the leading cause of death due to an ophthalmic condition. Uveal melanoma is often diagnosed at a late stage and has a strong propensity to hepatic metastasis. Recently, the most common driver mutations in uveal melanoma have been identifie...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Musi, Elgilda, Schwartz, Gary K., Yoo, Jae Hyuk, Odelberg, Shannon J., Li, Dean Y., Bonner, Michael Y., Selvakumar, Ponniah, Rao, Shikha, Gilbert, Linda C., Elsey, Justin, Arbiser, Jack L.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2019
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6633893/
https://ncbi.nlm.nih.gov/pubmed/31320995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27040
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars